Predicted inpatient costs based on inpatient LOS. Predicted inpatient costs in the 100 days after HCT based on inpatient LOS after adjusting for baseline demographic and clinical characteristics are shown. Note: inpatient costs were predicted based on a generalized linear model with gamma distribution, including LOS, baseline characteristics (ie, age, sex, type of malignancy, transplant type, prior antineoplastic treatments, and comorbidities) and posttransplant complications (ie, GVHD, CMV infection, other infections, and transfusion).